Dr. Susan Cu-Uvin is Professor of Obstetrics and Gynecology and Medicine at the Alpert School of Medicine, Brown University and Professor of Health Services, Policy and Practice at the School of Public Health. She is the Director of the Brown Global Health Initiative and Principal Investigator of a D43 HIV and Cervical CA Training Grant with MOI University in Kenya. She is the director of the Providence / Boston Center for AIDS Research (CFAR). She was the Director of the Immunology Center at the Miriam Hospital, Brown University, a clinic that now serves 1,700 HIV infected patients until mid-2009. She chaired the Women’s Health Committee of the Adult AIDS Clinical Trials Group (ACTG) from 2003-2006. She had been NIH funded since 1996 and the Principal Investigator of several RO1s to assess HIV dynamics in the female genital tract. She was a co-investigator of the CDC funded study to understand the natural history of HIV in women (HERS) and the study to understand the natural history of HIV and AIDS in the era of highly active antiretroviral therapy (SUN). She had a K24 Mid-Career Investigator Award in Patient Oriented Research which allowed her to mentor several junior investigators locally as well as internationally. She has been a co-investigator in studies related to mucosal immunity, microbicides, STI's and immune reconstitution in the female genital tract. She is a member of the Public Health Service Task Force/Perinatal Antiretroviral Guidelines Working Group, Office of AIDS Research Advisory Council and the NIH advisory committee on HIV related research in women and girls. She is a member of the NIH advisory committee on HIV related research in microbicides and chairs the HPV Working Group, USPHS/IDSA Guidelines for the Prevention and Treatment of Opportunistic Infections. She was the recipient of the Constance B. Wofsy Women’s Health Investigator Award from the AIDS Clinical Trials Group. She is a member of the Adult / Adolescent HIV Guidelines and the CDC STD Treatment Guidelines.
| Restar, Arjee J., Quilantang, Ma. Irene N., Surace, Anthony, Ogunbajo, Adedotun, Chan, Randolph, Adia, Alexander, Cu-Uvin, Susan, Operario, Don. "Characterizing Problematic Drug Use Among Transgender Women and Cisgender Men During the Emerging HIV Crisis in the Philippines: Implications for Policy Research." AIDS Education and Prevention, vol. 34, no. 2, 2022, pp. 116-130. |
| Guthrie KM, Rosen RK, Guillen M, Ramirez JJ, Vargas SE, Fava JL, Ham AS, Katz DF, Cu-Uvin S, Tumilty S, Smith KA, Buckheit KW, Buckheit RW , Jr. "Designing Dual Compartment HIV Prevention Products: Women's Sensory Perceptions and Experiences of Suppositories for Rectal and Vaginal Use." AIDS Research and Human Retroviruses, vol. 38, no. 7, 2022, pp. 601-610. |
| Thompson, Kathryn D., Meyers, David J., Lee, Yoojin, Cu-Uvin, Susan, Wilson, Ira B. "HIV-Positive and HIV-Negative Women with Medicaid Have Similar Rates of Stillbirth and Preterm Birth." Women's Health Reports, vol. 3, no. 1, 2022, pp. 1-9. |
| Fichorova, Raina N., DeLong, Allison K., Cu-Uvin, Susan, King, Caroline C., Jamieson, Denise J., Klein, Robert S., Sobel, Jack D., Vlahov, David, Yamamoto, Hidemi S., Mayer, Kenneth H. "Protozoan-Viral-Bacterial Co-Infections Alter Galectin Levels and Associated Immunity Mediators in the Female Genital Tract." Frontiers in Cellular and Infection Microbiology, vol. 11, 2021, pp. 649940. |
| Guigayoma, John, Bermudez, Amiel Nazer, Palatino, Maylin, Nazareno, Jennifer, Cu-Uvin, Susan, Operario, Don, Restar, Arjee. "Responsive Medical Providers and Recent HIV Medical Services Engagement Among Transgender Women and Cisgender Men Who Have Sex With Men in the Philippines." AIDS Education and Prevention, vol. 33, no. 6, 2021, pp. 495-510. |
| Politch JA, Cu-Uvin S, Moench TR, Tashima KT, Marathe JG, Guthrie KM, Cabral H, Nyhuis T, Brennan M, Zeitlin L, Spiegel HML, Mayer KH, Whaley KJ, Anderson DJ. "Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial." PLOS Medicine, vol. 18, no. 2, 2021, pp. e1003495. |
| van den Berg JJ, O'Keefe E, Davidson D, Fiellin DA, Kershaw T, Barbour RC, Cu-Uvin S, Cleary PD. "The development and evaluation of an HIV implementation science network in New England: lessons learned." Implementation Science Communications, vol. 2, no. 1, 2021, pp. 64. |
| Restar AJ, Adia A, Cu-Uvin S, Operario D. "Characterizing PrEP Awareness and Interest Among Filipina Transgender Women." AIDS Education and Prevention, vol. 32, no. 3, 2020, pp. 212-228. |
| Restar, Arjee J., Surace, Anthony, Jin, Harry, Edeza, Alberto, Ogunbajo, Adedotun, Goedel, William C., Adia, Alexander, Cu-Uvin, Susan, Operario, Don. "Integrating Pre- and Post-exposure Prophylaxes Programs for HIV Prevention Guidelines in Manila, Philippines." Sexuality Research and Social Policy, 2020. |
| Mehta N, Orangʼo O, Itsura P, Tonui P, Bussmann H, Bogers JP, Liu T, Cu-Uvin S. "Loop Electrosurgical Excision Procedure Treats Cervical Intraepithelial Neoplasia 2/3 Among HIV− and HIV+ Women in Kenya." Journal of Lower Genital Tract Disease, vol. 24, no. 1, 2020, pp. 21-26. |
| Restar AJ, Chan RCH, Adia A, Quilantang MI, Nazareno J, Hernandez L, Cu-Uvin S, Operario D. "Prioritizing HIV Services for Transgender Women and Men Who Have Sex With Men in Manila, Philippines: An Opportunity for HIV Provider Interventions." Journal of the Association of Nurses in AIDS Care, vol. 31, no. 4, 2020, pp. 405-416. |
| Peter IM, Deraney RN, Orango O, Philip T, Rosen B, Cu-Uvin S. "Radical hysterectomy for operable early cervical cancer in HIV ‐positive and HIV ‐negative women in western Kenya." International Journal of Gynecology & Obstetrics, vol. 148, no. 3, 2020, pp. 403-404. |
| Restar A, Ogunbajo A, Adia A, Nazareno J, Hernandez L, Sandfort T, Lurie M, Cu-Uvin S, Operario D. "Using structural equation modelling to characterise multilevel socioecological predictors and mediators of condom use among transgender women and cisgender men who have sex with men in the Philippines." BMJ Global Health, vol. 5, no. 7, 2020, pp. e002463. |
| Restar, Arjee J., Adia, Alexander, Nazareno, Jennifer, Hernandez, Laufred, Sandfort, Theo, Lurie, Mark, Cu-Uvin, Susan, Operario, Don. "Barriers and facilitators to uptake of condoms among Filipinx transgender women and cisgender men who have sex with men: A situated socio-ecological perspective." Global Public Health, vol. 15, no. 4, 2019, pp. 520-531. |
| Stringer EM, Kendall MA, Lockman S, Campbell TB, Nielsen-Saines K, Sawe F, Cu-Uvin S, Wu X, Currier JS. "Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy." PLoS ONE, vol. 13, no. 7, 2018, pp. e0199555. |
| Kojic EM, Conley L, Bush T, Cu-Uvin S, Unger ER, Henry K, Hammer J, Escota G, Darragh TM, Palefsky JM, Brooks JT, Patel P. "Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types Covered by Current HPV Vaccines Among HIV-Infected Women in the SUN Study." The Journal of Infectious Diseases, vol. 217, no. 10, 2018, pp. 1544-1552. |
| Adam, Gaelen P., Di, Mengyang, Cu-Uvin, Susan, Halladay, Christopher, Smith, Bryant T., Iyer, Suchitra, Trikalinos, Thomas A. "Strategies for improving the lives of US women aged 40 and above living with HIV/AIDS: an evidence map." Systematic Reviews, vol. 7, no. 1, 2018, pp. 25. |
| Jais, Mariel, Younes, Naji, Chapman, Stacey, Cu-Uvin, Susan, Ghosh, Mimi. "Reduced Levels and Bioactivity of Endogenous Protease Cathepsin D in Genital Tract Secretions of Postmenopausal Women." AIDS Research and Human Retroviruses, vol. 33, no. 5, 2017, pp. 407-409. |
| Sau MS, Balamane M, Lurie M, Harwell J, Welle E, Mean C, Cu-Uvin S. "Assessment of Prevention of Mother-to-Child Transmission HIV Services in the Bantey Meanchey Province in Cambodia." Journal of the International Association of Providers of AIDS Care, vol. 15, no. 4, 2016, pp. 345-9. |
| Chan, Philip A., Robinette, Ashley, Montgomery, Madeline, Almonte, Alexi, Cu-Uvin, Susan, Lonks, John R., Chapin, Kimberle C., Kojic, Erna M., Hardy, Erica J. "Extragenital Infections Caused byChlamydia trachomatisandNeisseria gonorrhoeae: A Review of the Literature." Infectious Diseases in Obstetrics and Gynecology, vol. 2016, 2016, pp. 5758387. |
| Sankapal, Soni, Gupta, Phalguni, Ratner, Deena, Ding, Ming, Shen, Chengli, Sanyal, Anwesha, Stolz, Donna, Cu-Uvin, Susan, Ramratnam, Bharat, Chen, Yue. "HIV Exposure to the Epithelia in Ectocervical and Colon Tissues Induces Inflammatory Cytokines Without Tight Junction Disruption." AIDS Research and Human Retroviruses, vol. 32, no. 10-11, 2016, pp. 1054-1066. |
| Rhodes, Corinne M., Cu-Uvin, Susan, Rana, Aadia I. "Pregnancy Desire, Partner Serodiscordance, and Partner HIV Disclosure among Reproductive Age HIV-Infected Women in an Urban Clinic." Infectious Diseases in Obstetrics and Gynecology, vol. 2016, 2016, pp. 8048457. |
| Jais M, Younes N, Chapman S, Cu-Uvin S, Ghosh M. "Reduced levels of genital tract immune biomarkers in postmenopausal women: implications for HIV acquisition." American Journal of Obstetrics and Gynecology, vol. 215, no. 3, 2016, pp. 324.e1-324.e10. |
| Hardy E, Cu-Uvin S. "Care of the HIV-infected pregnant woman in the developed world. Obstetric Medicine." obstetric medicine, vol. 8, no. 1, 2015, pp. 13-7. |
| Venkatesh KK, Cu-Uvin S. "Anatomic and hormonal changes in the female reproductive tract immune environment during the life cycle: implications for HIV/STI prevention research." American Journal of Reproductive Immunology, vol. 71, no. 6, 2014, pp. 495-504. |
| Sudenga SL, Wiener HW, King CC, Rompalo AM, Cu-Uvin S, Klein RS, Shah KV, Sobel JD, Jamieson DJ, Shrestha S. "Dense genotyping of immune-related loci identifies variants associated with clearance of HPV among HIV-positive women in the HIV epidemiology research study (HERS)." PLoS ONE, vol. 9, no. 6, 2014, pp. e99109. |
| Kantor R, Bettendorf D, Bosch RJ, Mann M, Katzenstein D, Cu-Uvin S, D'Aquila R, Frenkel L, Fiscus S, Coombs R, ACTG A5077 Study Team. "HIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077." PLoS ONE, vol. 9, no. 4, 2014, pp. e93537. |
| Khozaim K, Orang'o E, Christoffersen-Deb A, Itsura P, Oguda J, Muliro H, Ndiema J, Mwangi G, Strother M, Cu-Uvin S, Rosen B, Washington S. "Successes and challenges of establishing a cervical cancer screening and treatment program in western Kenya." International Journal of Gynecology & Obstetrics, vol. 124, no. 1, 2014, pp. 12-8. |
| Taylor LE, Foont JA, DeLong AK, Wurcel A, Linas BP, Chapman S, Maynard MA, Cu-Uvin S, Mayer KH. "The spectrum of undiagnosed hepatitis C virus infection in a US HIV clinic." AIDS Patient Care and STDs, vol. 28, no. 1, 2014, pp. 4-9. |
| Venkatesh KK, Cu-Uvin S. "Assessing the relationship between cervical ectopy and HIV susceptibility: implications for HIV prevention in women." American Journal of Reproductive Immunology, vol. 69 Suppl 1, 2013, pp. 68-73. |
| Fiscus SA, Cu-Uvin S, Eshete AT, Hughes MD, Bao Y, Hosseinipour M, Grinsztejn B, Badal-Faesen S, Dragavon J, Coombs RW, Braun K, Moran L, Hakim J, Flanigan T, Kumarasamy N, Campbell TB, A5185s Team. "Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy." Clinical Infectious Diseases, vol. 57, no. 2, 2013, pp. 290-7. |
| Westbrook ML, Garg S, Chapman S, Cu-Uvin S, Tashima KT, Taylor LE. "Hepatocellular carcinoma in HIV-infected women: two case reports." Rhode Island medical journal (2013), vol. 96, no. 1, 2013, pp. 21-4. |
| Venkatesh KK, DeLong AK, Kantor R, Chapman S, Ingersoll J, Kurpewski J, De Pasquale MP, D'Aquila R, Caliendo AM, Cu-Uvin S. "Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load." Journal of Women's Health, vol. 22, no. 4, 2013, pp. 330-8. |
| Anderson BL, Mendez-Figueroa H, Dahlke JD, Raker C, Hillier SL, Cu-Uvin S. "Pregnancy-induced changes in immune protection of the genital tract: defining normal." American Journal of Obstetrics and Gynecology, vol. 208, no. 4, 2013, pp. 321.e1-9. |
| Matthews LT, Smit JA, Cu-Uvin S, Cohan D. "Antiretrovirals and safer conception for HIV-serodiscordant couples." Current Opinion in HIV and AIDS, vol. 7, no. 6, 2012, pp. 569-78. |
| Kang M, Cu-Uvin S. "Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy." HIV medicine, vol. 13, no. 6, 2012, pp. 372-8. |
| Mabeya H, Khozaim K, Liu T, Orango O, Chumba D, Pisharodi L, Carter J, Cu-Uvin S. "Comparison of conventional cervical cytology versus visual inspection with acetic acid among human immunodeficiency virus-infected women in Western Kenya." Journal of Lower Genital Tract Disease, vol. 16, no. 2, 2012, pp. 92-97. |
| Nijhawan AE, Delong AK, Chapman S, Rana A, Kurpewski J, Ingersoll J, Caliendo AM, Cu-Uvin S. "Effect of HSV-2 suppressive therapy on genital tract HIV-1 RNA shedding among women on HAART: a pilot randomized controlled trial." Infectious Diseases in Obstetrics and Gynecology, vol. 2012, 2012, pp. 868526. |
| Anderson BL, Firnhaber C, Liu T, Swarts A, Siminya M, Ingersoll J, Caliendo AM, Cu-Uvin S. "Effect of trichomoniasis therapy on genital HIV viral burden among African women." Sexually Transmitted Diseases, vol. 39, no. 8, 2012, pp. 638-42. |
| Mukura LR, Ghosh M, Fahey JV, Cu-Uvin S, Wira CR. "Genital tract viral load in HIV Type 1-positive women correlates with specific cytokine levels in cervical-vaginal secretions but is not a determinant of infectious virus or anti-HIV activity." AIDS Research and Human Retroviruses, vol. 28, no. 11, 2012, pp. 1533-9. |
| Anderson JR, Cohan D, Cu-Uvin S. "HIV and reproduction: fertility, contraception, and preconception issues and interventions." Infectious Diseases in Obstetrics and Gynecology, vol. 2012, 2012, pp. 736864. |
| Anderson BL, Ghosh M, Raker C, Fahey J, Song Y, Rouse DJ, Wira CR, Cu-Uvin S. "In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women." American Journal of Obstetrics and Gynecology, vol. 207, no. 1, 2012, pp. 65.e1-10. |
| Nielsen-Saines K, Komarow L, Cu-Uvin S, Jourdain G, Klingman KL, Shapiro DE, Mofenson L, Moran L, Campbell TB, Hitti J, Fiscus S, Currier J, ACTG 5190/PACTG 1054 Study Team. "Infant outcomes after maternal antiretroviral exposure in resource-limited settings." Pediatrics, vol. 129, no. 6, 2012, pp. e1525-32. |
| Carten ML, Kiser JJ, Kwara A, Mawhinney S, Cu-Uvin S. "Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and Efavirenz." Infectious Diseases in Obstetrics and Gynecology, vol. 2012, 2012, pp. 137192. |
| Lahey T, Ghosh M, Fahey JV, Shen Z, Mukura LR, Song Y, Cu-Uvin S, Mayer KH, Wright PF, Kappes JC, Ochsenbauer C, Wira CR. "Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract." PLoS ONE, vol. 7, no. 6, 2012, pp. e38100. |
| Firth J, Wang CC, Gillani F, Alexander N, Dufort E, Rana A, Cu-Uvin S. "The changing face of HIV in pregnancy in Rhode Island 2004-2009." Infectious Diseases in Obstetrics and Gynecology, vol. 2012, 2012, pp. 895047. |
| Gallo MF, Jamieson DJ, Cu-Uvin S, Rompalo A, Klein RS, Sobel JD. "Accuracy of clinical diagnosis of bacterial vaginosis by human immunodeficiency virus infection status." Sexually Transmitted Diseases, vol. 38, no. 4, 2011, pp. 270-4. |
| Gallo MF, Warner L, King CC, Sobel JD, Klein RS, Cu-Uvin S, Rompalo AM, Jamieson DJ. "Association between semen exposure and incident bacterial vaginosis." Infectious Diseases in Obstetrics and Gynecology, vol. 2011, 2011, pp. 842652. |
| King CC, Jamieson DJ, Wiener J, Cu-Uvin S, Klein RS, Rompalo AM, Shah KV, Sobel JD. "Bacterial vaginosis and the natural history of human papillomavirus." Infectious Diseases in Obstetrics and Gynecology, vol. 2011, 2011, pp. 319460. |
| Anderson BL, Cu-Uvin S. "Clinical parameters essential to methodology and interpretation of mucosal responses." American Journal of Reproductive Immunology, vol. 65, no. 3, 2011, pp. 352-60. |
| Lim K, Davidson A, Harwell J, Thay S, Boardman LA, Feller E, Cu-Uvin S. "Comparing Visual Inspection with Acetic Acid to Cytology in Detection of Precancerous Lesions of the Cervix in HIV-Infected Cambodian Women." Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002), vol. 10, no. 5, 2011, pp. 283-6. |
| Gallo MF, Sobel JD, Rompalo AM, Cu-Uvin S, Schoenbaum E, Jamieson DJ. "Discordance between spermatozoa detection and self-reported semen exposure." Sexually Transmitted Diseases, vol. 38, no. 10, 2011, pp. 909-12. |
| Mitchell CE, Hudgens MG, King CC, Cu-Uvin S, Lo Y, Rompalo A, Sobel J, Smith JS. "Discrete-time semi-Markov modeling of human papillomavirus persistence." Statistics in Medicine, vol. 30, no. 17, 2011, pp. 2160-70. |
| Cu-Uvin S, Caliendo AM. "Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load." AIDS, vol. 25, no. 6, 2011, pp. 880-1. |
| Kojic EM, Cu-Uvin S, Conley L, Bush T, Onyekwuluje J, Swan DC, Unger ER, Henry K, Hammer JH, Overton ET, Darragh TM, Palefsky JM, Vellozzi C, Patel P, Brooks JT. "Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study)." Sexually Transmitted Diseases, vol. 38, no. 4, 2011, pp. 253-9. |
| Chibwesha CJ, Cu-Uvin S. "See-and-treat approaches to cervical cancer prevention for HIV-infected women." Current HIV/AIDS Reports, vol. 8, no. 3, 2011, pp. 192-9. |
| Anderson BL, Cu-Uvin S, Raker CA, Fitzsimmons C, Hillier SL. "Subtle perturbations of genital microflora alter mucosal immunity among low-risk pregnant women." Acta obstetricia et gynecologica Scandinavica, vol. 90, no. 5, 2011, pp. 510-5. |
| Nijhawan AE, DeLong AK, Celentano DD, Klein RS, Sobel JD, Jamieson DJ, Cu-Uvin S. "The association between Trichomonas infection and incarceration in HIV-seropositive and at-risk HIV-seronegative women." Sexually Transmitted Diseases, vol. 38, no. 12, 2011, pp. 1094-100. |
| Eleanya C, Delong A, Chapman S, Nijhawan A, Ingersoll J, Caliendo AM, Cu-Uvin S. "Addition of Acyclovir does not affect Adherence to HAART in HIV-1/ HSV-2 Co-Infected Women." Journal of AIDS & clinical research, vol. 1, no. 4, 2010. |
| Ghosh M, Fahey JV, Shen Z, Lahey T, Cu-Uvin S, Wu Z, Mayer K, Wright PF, Kappes JC, Ochsenbauer C, Wira CR. "Anti-HIV Activity in Cervical-Vaginal Secretions from HIV-Positive and -Negative Women Correlate with Innate Antimicrobial Levels and IgG Antibodies." PLoS ONE, vol. 5, no. 6, 2010, pp. e11366. |
| Kassis N, Heard A, Sprawka N, Cu-Uvin S, Anderson B. "Antiretroviral-induced hepatotoxicity presenting as nonreassuring fetal testing." Obstetrics and gynecology, vol. 116 Suppl 2, 2010, pp. 515-7. |
| Seaman WT, Andrews E, Couch M, Kojic EM, Cu-Uvin S, Palefsky J, Deal AM, Webster-Cyriaque J. "Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR." Virology Journal, vol. 7, 2010, pp. 194. |
| Conley L, Bush T, Darragh TM, Palefsky JM, Unger ER, Patel P, Kojic EM, Cu-Uvin S, Martin H, Overton ET, Hammer J, Henry K, Vellozzi C, Wood K, Brooks JT, Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN Study) Investigators. "Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States." The Journal of Infectious Diseases, vol. 202, no. 10, 2010, pp. 1567-76. |
| Cu-Uvin S, DeLong AK, Venkatesh KK, Hogan JW, Ingersoll J, Kurpewski J, De Pasquale MP, D'Aquila R, Caliendo AM. "Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load." AIDS, vol. 24, no. 16, 2010, pp. 2489-97. |
| Theiler RN, Farr SL, Karon JM, Paramsothy P, Viscidi R, Duerr A, Cu-Uvin S, Sobel J, Shah K, Klein RS, Jamieson DJ. "High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding." Obstetrics and gynecology, vol. 115, no. 6, 2010, pp. 1150-8. |
| Firth J, Jeyaseelan L, Christina S, Vonbara V, Jeyaseelan V, Elan S, Abraham S, Joseph I, David S, Cu-Uvin S, Lurie M, Wanke C, Lionel J. "HIV-1 seroprevalence and awareness of mother-to-child transmission issues among women seeking antenatal care in Tamil Nadu, India." Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002), vol. 9, no. 4, 2010, pp. 206-13. |
| Ghosh M, Shen Z, Fahey JV, Cu-Uvin S, Mayer K, Wira CR. "Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract." Immunology, vol. 129, no. 2, 2010, pp. 207-19. |
| Gillani FS, Zaller ND, Zeller K, Rich JD, Cu-Uvin S, Flanigan TP, Carpenter CC. "Changes in demographics and risk factors among persons living with HIV in an academic medical center from 2003-2007." Medicine and health, Rhode Island, vol. 92, no. 7, 2009, pp. 237-40. |
| Mitchell C, Moreira C, Fredricks D, Paul K, Caliendo AM, Kurpewski J, Ingersoll J, Cu-Uvin S. "Detection of fastidious vaginal bacteria in women with HIV infection and bacterial vaginosis." Infectious Diseases in Obstetrics and Gynecology, vol. 2009, 2009, pp. 236919. |
| Moreira C, Venkatesh KK, DeLong A, Liu T, Kurpewski J, Ingersoll J, Caliendo AM, Cu-Uvin S. "Effect of treatment of asymptomatic bacterial vaginosis on HIV-1 shedding in the genital tract among women on antiretroviral therapy: a pilot study." Clinical Infectious Diseases, vol. 49, no. 6, 2009, pp. 991-2. |
| Beckwith CG, DeLong AK, Desjardins SF, Gillani F, Bazerman L, Mitty JA, Ross H, Cu-Uvin S. "HIV infection in refugees: a case-control analysis of refugees in Rhode Island." International Journal of Infectious Diseases, vol. 13, no. 2, 2009, pp. 186-92. |
| Blood, E., Beckwith, C., Bazerman, L., Cu-Uvin, S., & Mitty, J. "Pregnancy among HIV-infected refugees in Rhode Island." AIDS Care, vol. 21, no. 2, 2009, pp. 207-11. |
| Anderson BL, Cu-Uvin S. "Pregnancy and optimal care of HIV-infected patients." Clinical Infectious Diseases, vol. 48, no. 4, 2009, pp. 449-55. |
| Kojic EM, Wang CC, Firth JA, Gopalakrishnan G, Cu-Uvin S. "Special care issues of women living with HIV/AIDS." Medicine and health, Rhode Island, vol. 92, no. 7, 2009, pp. 229-30. |
| Paramsothy P, Jamieson DJ, Heilig CM, Schuman PC, Klein RS, Shah KV, Rompalo AM, Cu-Uvin S, Duerr A. "The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology." Obstetrics and gynecology, vol. 113, no. 1, 2009, pp. 26-31. |
| Kwara A, Delong A, Rezk N, Hogan J, Burtwell H, Chapman S, Moreira CC, Kurpewski J, Ingersoll J, Caliendo AM, Kashuba A, Cu-Uvin S. "Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy." Clinical Infectious Diseases, vol. 46, no. 5, 2008, pp. 719-25. |
| Boardman LA, Cotter K, Raker C, Cu-Uvin S. "Cervical intraepithelial neoplasia grade 2 or worse in human immunodeficiency virus-infected women with mildly abnormal cervical cytology." Obstetrics and gynecology, vol. 112, no. 2 Pt 1, 2008, pp. 238-43. |
| Anderson BL, Cu-Uvin S. "Determinants of HIV shedding in the lower genital tract of women." Current Infectious Disease Reports, vol. 10, no. 6, 2008, pp. 505-11. |
| Anderson BL, Wang CC, Delong AK, Liu T, Kojic EM, Kurpewski J, Ingersoll J, Mayer K, Caliendo AM, Cu-Uvin S. "Genital tract leukocytes and shedding of genital HIV type 1 RNA." Clinical Infectious Diseases, vol. 47, no. 9, 2008, pp. 1216-21. |
| Lionel J, Aleyamma TK, Varghese L, Buck J, Gopalakrishnan G, Chaguturu S, Cu-Uvin S, Mayer K. "HIV and obstetric complications and fetal outcomes in Vellore, India." Tropical doctor, vol. 38, no. 3, 2008, pp. 144-6. |
| Chan PA, Wakeman SE, Flanigan T, Cu-Uvin S, Kojic E, Kantor R. "HIV-2 diagnosis and quantification in high-risk patients." AIDS research and therapy, vol. 5, 2008, pp. 18. |
| Brim NM, Cu-Uvin S, Hu SL, O'Bell JW. "Bone disease and pathologic fractures in a patient with tenofovir-induced Fanconi syndrome." The AIDS reader, vol. 17, no. 6, 2007, pp. 322-8, C3. |
| Cu-Uvin S, Pugatch D. "Brown's involvement in the health of less developed countries." Medicine and health, Rhode Island, vol. 90, no. 11, 2007, pp. 340-1. |
| Losikoff P, Fichorova R, Snyder B, Rodriguez I, Cu-Uvin S, Harwell J, Mayer KH. "Genital tract interleukin-8 but not interleukin-1beta or interleukin-6 concentration is associated with bacterial vaginosis and its clearance in HIV-infected and HIV-uninfected women." Infectious Diseases in Obstetrics and Gynecology, vol. 2007, 2007, pp. 92307. |
| Flanigan TP, Wools-Kaloustain K, Harwell J, Cu-Uvin S, Kimaiyo S, Carter EJ. "Highly Active Antiretroviral Therapy (HAART)--Plus: Next Steps to Enhance HAART in Resource-Limited Areas?." Clinical Infectious Diseases, vol. 45, no. 11, 2007, pp. 1499-501. |
| Kojic EM, Wang CC, Cu-Uvin S. "HIV and menopause: a review." Journal of Women's Health, vol. 16, no. 10, 2007, pp. 1402-11. |
| Tohill BC, Heilig CM, Klein RS, Rompalo A, Cu-Uvin S, Piwoz EG, Jamieson DJ, Duerr A. "Nutritional biomarkers associated with gynecological conditions among US women with or at risk of HIV infection." The American journal of clinical nutrition, vol. 85, no. 5, 2007, pp. 1327-34. |
| Massad LS, Fazzari MJ, Anastos K, Klein RS, Minkoff H, Jamieson DJ, Duerr A, Celentano D, Gange S, Cu-Uvin S, Young M, Watts DH, Levine AM, Schuman P, Harris TG, Strickler HD. "Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV." Journal of Lower Genital Tract Disease, vol. 11, no. 2, 2007, pp. 90-7. |
| Kojic EM, Cu-Uvin S. "Special care issues of women living with HIV-AIDS." Infectious disease clinics of North America, vol. 21, no. 1, 2007, pp. 133-48, ix. |
| Quayle AJ, Kourtis AP, Cu-Uvin S, Politch JA, Yang H, Bowman FP, Shah M, Anderson DJ, Crowley-Nowick P, Duerr A. "T-lymphocyte profile and total and virus-specific immunoglobulin concentrations in the cervix of HIV-1-infected women." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 44, no. 3, 2007, pp. 292-8. |
| Kojic EM, Cu-Uvin S. "Update: human papillomavirus infection remains highly prevalent and persistent among HIV-infected individuals." Current opinion in oncology, vol. 19, no. 5, 2007, pp. 464-9. |
| Cu-Uvin S, Snyder B, Harwell JI, Hogan J, Chibwesha C, Hanley D, Ingersoll J, Kurpewski J, Mayer KH, Caliendo AM. "Association between paired plasma and cervicovaginal lavage fluid HIV-1 RNA levels during 36 months." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 42, no. 5, 2006, pp. 584-7. |
| Duerr A, Paramsothy P, Jamieson DJ, Heilig CM, Klein RS, Cu-Uvin S, Schuman P, Anderson JR, HIV Epidemiology Research Study. "Effect of HIV infection on atypical squamous cells of undetermined significance." Clinical Infectious Diseases, vol. 42, no. 6, 2006, pp. 855-61. |
| Jacobson JM, Pat Bucy R, Spritzler J, Saag MS, Eron JJ Jr, Coombs RW, Wang R, Fox L, Johnson VA, Cu-Uvin S, Cohn SE, Mildvan D, O'Neill D, Janik J, Purdue L, O'Connor DK, Vita CD, Frank I, National Institute of Allergy and Infectious Diseases-AIDS Clinical Trials Group 5068 Protocol Team. "Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068." The Journal of Infectious Diseases, vol. 194, no. 5, 2006, pp. 623-32. |
| Koshiol J, Schroeder J, Jamieson DJ, Marshall SW, Duerr A, Heilig CM, Shah KV, Klein RS, Cu-Uvin S, Schuman P, Celentano D, Smith JS. "Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women." American Journal of Epidemiology, vol. 164, no. 2, 2006, pp. 176-83. |
| Koshiol JE, Schroeder JC, Jamieson DJ, Marshall SW, Duerr A, Heilig CM, Shah KV, Klein RS, Cu-Uvin S, Schuman P, Celentano D, Smith JS. "Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus." International Journal of Cancer, vol. 119, no. 7, 2006, pp. 1623-9. |
| Jamieson DJ, Paramsothy P, Cu-Uvin S, Duerr A, HIV Epidemiology Research Study Group. "Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus." Obstetrics and gynecology, vol. 107, no. 5, 2006, pp. 1023-8. |
| Cu-Uvin S. "Effect of the menstrual cycle on virological parameters." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 38 Suppl 1, 2005, pp. S33-4. |
| Viscidi RP, Snyder B, Cu-Uvin S, Hogan JW, Clayman B, Klein RS, Sobel J, Shah KV. "Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women." Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 1, 2005, pp. 283-8. |
| Newstein M, Losikoff P, Caliendo A, Ingersoll J, Kurpewski J, Hanley D, Cerezo J, Ramratnam B, Cu-Uvin S. "Prevalence and persistence of nonnucleoside reverse transcriptase inhibitor mutations in the female genital tract." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 38, no. 3, 2005, pp. 364-6. |
| Morris AB, Dobles AR, Cu-Uvin S, Zorrilla C, Anderson J, Harwell JI, Keller J, Garb J. "Protease inhibitor use in 233 pregnancies." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 40, no. 1, 2005, pp. 30-3. |
| Paramsothy P, Duerr A, Heilig CM, Cu-Uvin S, Anderson JR, Schuman P, Klein RS, HIV Epidemiology Research (HER) Study Group. "Abnormal vaginal cytology in HIV-infected and at-risk women after hysterectomy." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 35, no. 5, 2004, pp. 484-91. |
| Cu-Uvin S, Jenny-Avital ER. "Antiretroviral rounds. Can you be positive that she's positive?." AIDS clinical care, vol. 16, no. 12, 2004, pp. 98-9. |
| Theng T, Sok P, Pugatch D, Harwell JI, Rufner KM, Chhi Mean V, Mayer KH, Cu-Uvin S. "HIV-1 cord-blood seroprevalence of parturient women in Sihanoukville, Cambodia." International journal of STD & AIDS, vol. 15, no. 6, 2004, pp. 419-21. |
| Quayle AJ, Shah M, Cu-Uvin S, Politch JA, Chou C, Anderson DJ, Tuomala R, Crowley-Nowick PA, Duerr A. "Implications of blood contamination for assessment of local cellular immunity in the endocervix." AIDS Research and Human Retroviruses, vol. 20, no. 5, 2004, pp. 543-6. |
| Min SS, Corbett AH, Rezk N, Cu-Uvin S, Fiscus SA, Petch L, Cohen MS, Kashuba AD. "Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 37, no. 5, 2004, pp. 1577-80. |
| Tohill BC, Heilig CM, Klein RS, Rompalo A, Cu-Uvin S, Brown W, Duerr A. "Vaginal flora morphotypic profiles and assessment of bacterial vaginosis in women at risk for HIV infection." Infectious Diseases in Obstetrics and Gynecology, vol. 12, no. 3-4, 2004, pp. 121-6. |
| Harwell JI, Moench T, Mayer KH, Chapman S, Rodriguez I, Cu-Uvin S. "A pilot study of treatment of bacterial vaginosis with a buffering vaginal microbicide." Journal of Women's Health, vol. 12, no. 3, 2003, pp. 255-9. |
| Harwell JI, Flanigan TP, Mitty JA, Macalino GE, Caliendo AM, Ingersoll J, Stenzel MS, Carpenter CC, Cu-Uvin S. "Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence." AIDS, vol. 17, no. 13, 2003, pp. 1990-3. |
| Natividad-Villanueva GU, Santiago E, Manalastas RM Jr, Brown HW, Ingersoll J, Caliendo AM, Mayer KH, Cu-Uvin S. "Human immunodeficiency virus in plasma and cervicovaginal secretions in Filipino women." International journal of STD & AIDS, vol. 14, no. 12, 2003, pp. 826-9. |
| Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, Duerr A, Massad LS, Celentano DD, Hall C, Fazzari M, Cu-Uvin S, Bacon M, Schuman P, Levine AM, Durante AJ, Gange S, Melnick S, Burk RD. "Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women." JNCI Journal of the National Cancer Institute, vol. 95, no. 14, 2003, pp. 1062-71. |
| Duerr A, Heilig CM, Meikle SF, Cu-Uvin S, Klein RS, Rompalo A, Sobel JD, HER Study Group. "Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women: Risk factors and severity." Obstetrics and gynecology, vol. 101, no. 3, 2003, pp. 548-56. |
| Schuman P, Ohmit SE, Klein RS, Duerr A, Cu-Uvin S, Jamieson DJ, Anderson J, Shah KV, HIV Epidemiology Research Study (HERS) Group. "Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women." The Journal of Infectious Diseases, vol. 188, no. 1, 2003, pp. 128-36. |
| Viscidi RP, Ahdieh-Grant L, Clayman B, Fox K, Massad LS, Cu-Uvin S, Shah KV, Anastos KM, Squires KE, Duerr A, Jamieson DJ, Burk RD, Klein RS, Minkoff H, Palefsky J, Strickler H, Schuman P, Piessens E, Miotti P. "Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women." The Journal of Infectious Diseases, vol. 187, no. 2, 2003, pp. 194-205. |
| Harlow SD, Cohen M, Ohmit SE, Schuman P, Cu-Uvin S, Lin X, Greenblatt R, Gurtman A, Khalsa A, Minkoff H, Young MA, Klein RS. "Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virus." American Journal of Obstetrics and Gynecology, vol. 188, no. 4, 2003, pp. 881-6. |
| Larsson M, Wilkens DT, Fonteneau JF, Beadle TJ, Merritt MJ, Kost RG, Haslett PA, Cu-Uvin S, Bhardwaj N, Nixon DF, Shacklett BL. "Amplification of low-frequency antiviral CD8 T cell responses using autologous dendritic cells." AIDS, vol. 16, no. 2, 2002, pp. 171-80. |
| Jamieson DJ, Duerr A, Burk R, Klein RS, Paramsothy P, Schuman P, Cu-Uvin S, Shah K, HIV Epidemiology Research Study (HERS) Group. "Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection." American Journal of Obstetrics and Gynecology, vol. 186, no. 1, 2002, pp. 21-7. |
| Kozlowski PA, Williams SB, Lynch RM, Flanigan TP, Patterson RR, Cu-Uvin S, Neutra MR. "Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle." The Journal of Immunology, vol. 169, no. 1, 2002, pp. 566-74. |
| Williams SB, Flanigan TP, Cu-Uvin S, Mayer K, Williams P, Ettore CA, Artenstein AW, Duerr A, VanCott TC. "Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1." Clinical Infectious Diseases, vol. 35, no. 5, 2002, pp. 611-7. |
| Cu-Uvin S, Ko H, Jamieson DJ, Hogan JW, Schuman P, Anderson J, Klein RS, HIV Epidemiology Research Study (HERS) Group. "Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection." Clinical Infectious Diseases, vol. 34, no. 10, 2002, pp. 1406-11. |
| Silverberg MJ, Ahdieh L, Munoz A, Anastos K, Burk RD, Cu-Uvin S, Duerr A, Greenblatt RM, Klein RS, Massad S, Minkoff H, Muderspach L, Palefsky J, Piessens E, Schuman P, Watts H, Shah KV. "The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts." Sexually Transmitted Diseases, vol. 29, no. 8, 2002, pp. 427-35. |
| Reichelderfer PS, Kovacs A, Wright DJ, Landay A, Cu-Uvin S, Burns DN, Cohn J, Coombs RW. "The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions." The Journal of Infectious Diseases, vol. 186, no. 5, 2002, pp. 726-8; author reply 728-9. |
| Al-Harthi L, Kovacs A, Coombs RW, Reichelderfer PS, Wright DJ, Cohen MH, Cohn J, Cu-Uvin S, Watts H, Lewis S, Beckner S, Landay A, WHS 001 Study Team. "A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding." AIDS, vol. 15, no. 12, 2001, pp. 1535-43. |
| Warren D, Klein RS, Sobel J, Kieke B Jr, Brown W, Schuman P, Anderson J, Cu-Uvin S, Mayer K, Jamieson DJ, Holmberg S, Duerr A, HIV Epidemiology Research Study Group. "A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection." Infectious Diseases in Obstetrics and Gynecology, vol. 9, no. 3, 2001, pp. 133-41. |
| Cu-Uvin S, Hogan JW, Caliendo AM, Harwell J, Mayer KH, Carpenter CC, HIV Epidemiology Research Study. "Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract." Clinical Infectious Diseases, vol. 33, no. 6, 2001, pp. 894-6. |
| Brown H, Vallabhaneni S, Solomon S, Mothi S, McGarvey S, Jackson T, Putcha M, Brenner S, Mate K, Cu-Uvin S. "Attitudes towards prenatal HIV testing and treatment among pregnant women in southern India." International journal of STD & AIDS, vol. 12, no. 6, 2001, pp. 390-4. |
| Simbulan NP, Aguilar AS, Flanigan T, Cu-Uvin S. "High-risk behaviors and the prevalence of sexually transmitted diseases among women prisoners at the women state penitentiary in Metro Manila." Social Science & Medicine, vol. 52, no. 4, 2001, pp. 599-608. |
| Jamieson DJ, Duerr A, Klein RS, Paramsothy P, Brown W, Cu-Uvin S, Rompalo A, Sobel J. "Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study." Obstetrics and gynecology, vol. 98, no. 4, 2001, pp. 656-63. |
| Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, Safaeian M, Astemborski J, Daniel R, Shah K. "Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women." The Journal of Infectious Diseases, vol. 184, no. 6, 2001, pp. 682-90. |
| Nahvi S, Flanigan T, Cu-Uvin S. "Processing of semen from human immunodeficiency virus-seropositive men for use in insemination of seronegative women." American Journal of Obstetrics and Gynecology, vol. 184, no. 5, 2001, pp. 1048-9. |
| Mayer KH, Peipert J, Fleming T, Fullem A, Moench T, Cu-Uvin S, Bentley M, Chesney M, Rosenberg Z. "Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States." Clinical Infectious Diseases, vol. 32, no. 3, 2001, pp. 476-82. |
| Coombs RW, Wright DJ, Reichelderfer PS, Burns DN, Cohn J, Cu-Uvin S, Baron PA, Cohen MH, Landay AL, Lewis S, Kovacs A, Women's Health Study 001 Team. "Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women." The Journal of Infectious Diseases, vol. 184, no. 9, 2001, pp. 1187-91. |
| Farley JL, Mitty JA, Lally MA, Burzynski JN, Tashima K, Rich JD, Cu-Uvin S, Spaulding A, Normandie L, Snead M, Flanigan TP. "Comprehensive Medical Care among HIV-Positive Incarcerated Women: The Rhode Island Experience." Journal of women's health & gender-based medicine, vol. 9, no. 1, 2000, pp. 51-6. |
| Cu-Uvin S, Caliendo AM, Reinert S, Chang A, Juliano-Remollino C, Flanigan TP, Mayer KH, Carpenter CC. "Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA." AIDS, vol. 14, no. 4, 2000, pp. 415-21. |
| Harlow SD, Schuman P, Cohen M, Ohmit SE, Cu-Uvin S, Lin X, Anastos K, Burns D, Greenblatt R, Minkoff H, Muderspach L, Rompalo A, Warren D, Young MA, Klein RS. "Effect of HIV infection on menstrual cycle length." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 24, no. 1, 2000, pp. 68-75. |
| Reichelderfer PS, Coombs RW, Wright DJ, Cohn J, Burns DN, Cu-Uvin S, Baron PA, Coheng MH, Landay AL, Beckner SK, Lewis SR, Kovacs AA. "Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team." AIDS, vol. 14, no. 14, 2000, pp. 2101-7. |
| Cu-Uvin S, Wright DJ, Anderson D, Kovacs A, Watts DH, Cohn J, Landay A, Reichelderfer PS. "Hormonal levels among HIV-1-seropositive women compared with high-risk HIV-seronegative women during the menstrual cycle. Women's Health Study (WHS) 001 and WHS 001a Study Team." Journal of women's health & gender-based medicine, vol. 9, no. 8, 2000, pp. 857-63. |
| Daniel RW, Ahdieh L, Hayden D, Cu-Uvin S, Shah KV. "Intra-laboratory reproducibility of human papillomavirus identification in cervical specimens by a polymerase chain reaction-based assay." Journal of Clinical Virology, vol. 19, no. 3, 2000, pp. 187-93. |
| Newmann S, Sarin P, Kumarasamy N, Amalraj E, Rogers M, Madhivanan P, Flanigan T, Cu-Uvin S, McGarvey S, Mayer K, Solomon S. "Marriage, monogamy and HIV: a profile of HIV-infected women in south India." International journal of STD & AIDS, vol. 11, no. 4, 2000, pp. 250-3. |
| Kozlowski PA, Lynch RM, Patterson RR, Cu-Uvin S, Flanigan TP, Neutra MR. "Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 24, no. 4, 2000, pp. 297-309. |
| Morris AB, Cu-Uvin S, Harwell JI, Garb J, Zorrilla C, Vajaranant M, Dobles AR, Jones TB, Carlan S, Allen DY. "Multicenter review of protease inhibitors in 89 pregnancies." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 25, no. 4, 2000, pp. 306-11. |
| Shacklett BL, Cu-Uvin S, Beadle TJ, Pace CA, Fast NM, Donahue SM, Caliendo AM, Flanigan TP, Carpenter CC, Nixon DF. "Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface." AIDS, vol. 14, no. 13, 2000, pp. 1911-5. |
| Kozlowski PA, Cu-Uvin S, Neutra MR, Flanigan TP. "Mucosal vaccination strategies for women." The Journal of Infectious Diseases, vol. 179 Suppl 3, 1999, pp. S493-8. |
| Cu-Uvin S, Hogan JW, Warren D, Klein RS, Peipert J, Schuman P, Holmberg S, Anderson J, Schoenbaum E, Vlahov D, Mayer KH. "Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group." Clinical Infectious Diseases, vol. 29, no. 5, 1999, pp. 1145-50. |
| Star J, Powrie R, Cu-Uvin S, Carpenter CC. "Should women with human immunodeficiency virus be delivered by cesarean?." Obstetrics and gynecology, vol. 94, no. 5 Pt 1, 1999, pp. 799-801. |
| Quesnel A, Cu-Uvin S, Murphy D, Ashley RL, Flanigan T, Neutra MR. "Comparative analysis of methods for collection and measurement of immunoglobulins in cervical and vaginal secretions of women." Journal of immunological methods, vol. 202, no. 2, 1997, pp. 153-61. |
| Kozlowski PA, Cu-Uvin S, Neutra MR, Flanigan TP. "Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women." Infection and Immunity, vol. 65, no. 4, 1997, pp. 1387-94. |
| Ruiz R, Cu-Uvin S, Fiore T, Flanigan TP. "Toxoplasmosis in HIV-positive women: seroprevalence and the role of prophylaxis in preventing disease." AIDS, vol. 11, no. 1, 1997, pp. 119-20. |
| Cu-Uvin S, Flanigan TP, Rich JD, Mileno MD, Mayer KH, Carpenter CC. "Human immunodeficiency virus infection and acquired immunodeficiency syndrome among North American women." The American Journal of Medicine, vol. 101, no. 3, 1996, pp. 316-22. |
| Boardman LA, Peipert JF, Cooper AS, Cu-Uvin S, Flanigan T, Raphael SI. "Cytologic-histologic discrepancy in human immunodeficiency virus-positive women referred to a colposcopy clinic." Obstetrics and gynecology, vol. 84, no. 6, 1994, pp. 1016-20. |
| Flanigan TP, Cu-Uvin S, Fiore T, Vigilante K, Kizirian J, Carpenter CC. "HIV infection in Rhode Island women." Rhode Island medicine, vol. 76, no. 9, 1993, pp. 459-60, 465-6. |
Dr. Cu-Uvin's research focuses on Human Immunideficiency Virus (HIV) in women primarily in understanding the effect of antiretroviral therapy on HIV shedding in the female genital tract. She is also involved in research on Sexually Transmitted Diseases (STDs): human papilloma virus (HPV, genital warts) in the cervix and anal canal of HIV infected women, cervical/anal dysplasia or cancer, HPV vaccines, herpes and bacterial vaginosis. She collaborates on studies of microbicides to prevent HIV transmission.
GRANTS, ACTIVE
1R01AI108538 (Tsibris)
NIH 04/01/14-03/31/19
$116,771 1.8 calendar months
HIV-1 Reservoir Dynamics in the Female Genital Tract
The aim of this project is to assess HIV reservoir in the female genital tract compared to blood.
Role: Co-Investigator
5P30AI042853-16S (Carpenter)
NIH 04/01/14-03/31/15
$364,969 1.8 calendar months
Leeping Ahead: “See and LEEP” Training for Primary Care Providers in Kenya
The aim of this project is to demonstrate the feasibility of training Kenyan Primary Care Providers to perform cervical cancer screening with VIA and LEEP
Role: Co-Investigator
1RO1HD072693-02 (Ramratnam/Cu-Uvin)
NIH 04/01/12-02/28/17
$71,539 1.2 Calendar Months
Reproductive Hormones and HIV-1 Acquisition
The aims of this project are: (Aim 1) To quantify the effect of exogenous and endogenous reproductive hormones on HIV-1 susceptibility of the reproductive tract, (Aim 2) To determine whether reproductive hormones alter the mechanisms responsible for HIV-1 transmission through cervicovaginal epithelia, (Aim 3) To quantify the effect of reproductive hormones on HIV-1 dependency factors in the female genital tract. We will assemble a longitudinal cohort of healthy pre- and post-menopausal HIV-1 uninfected women.
Role: PI
**5P30AI042853-16 (Carpenter)
NIH/NIAID 09/01/98-06/30/17
$ 683,099 1.2 calendar months
Lifespan/Tufts/Brown Center for AIDS Research
This is a multi-institutional Center for AIDS Research for which three of the five broad goals are directly relevant to the current grant, i.e., 1) To stimulate translational AIDS research with women, minorities and other underrepresented groups; 2) To integrate nutritional assessment/intervention and outcomes analysis into clinical research; and 3) To encourage multidisciplinary research on the clinical issues surrounding new therapies and the accompanying extended survival of HIV-seropositive patients.
Administrative Core – Associate Director
***5P30AI042853-16 (Carpenter)
NIH/NIAID 09/01/98-06/30/17
$123,519 1.8 calendar months
Lifespan/Tufts/Brown Center for AIDS Research
This is a multi-institutional Center for AIDS Research for which three of the five broad goals are directly relevant to the current grant, i.e., 1) To stimulate translational AIDS research with women, minorities and other underrepresented groups; 2) To integrate nutritional assessment/intervention and outcomes analysis into clinical research; and 3) To encourage multidisciplinary research on the clinical issues surrounding new therapies and the accompanying extended survival of HIV-seropositive patients.
HIV and Women's Core - Co- Director
7D43TW000237-19 (Cu-Uvin)
NIH/FIC 05/1/11-04/30/15
$702,341 1.8 Calendar Months
AIDS International Research and Training Program (Fogarty Center)
This training grant funds the U.S. and overseas education of clinical, laboratory and behavioral AIDS researchers in the Philippines, Indonesia, India, Bangladesh, and Cambodia. The training activities include tutorials, degree programs, and in country courses which educate the trainees in current epidemiological, laboratory, and behavioral techniques.
Role: PI
2UM1AI069412-08 (Tashima)
NIH/NIAID 12/01/13-11/30/20
$125,600 .12 calendar months
Adult Therapeutic Clinical Trials Program for HIV/AIDS
The goal of this project is to participate in multi-center HIV/AIDS therapeutic trials.
Role: Co-Investigator
5H76HA00018 (Montague)
DHHS/HRSA 05/01/94-12/31/14
$381,287 .6 calendar months
Ryan White Part C - Outpatient Early Intervention Services with Respect to HIV Disease
The goal of this project is to provide intervention services related to HIV in an outpatient setting.
Role: Co-Investigator
5U19AI096398-03 (Anderson)
NIH 07/01/11-06/31/16
$34,514 .72 calendar months
Monoclonal Antibody-based Multipurpose Microbicides
This project will shed light on mechanisms of mAb antiviral efficacy in the vaginal environment and further the development of monoclonal antibodies as topical vaginal microbicides to protect against sexually transmitted infections, including HIV/AIDS and HSV/genital herpes.
Role: Co-Investigator
1R03AI102837-02 (Ghosh)
NIH 04/15/12-03/31/14
$30,371 .6 calendar months
Anti-HIV Activity in Genital Tract Secretions of Postmenopausal Women
The goal of this project is to examine innate immune functions in the genital tract of postmenopausal women to determine whether a less robust immune system might make these women more susceptible to acquiring as well as transmitting HIV.
Role: Co-Investigator
GRANTS, COMPLETED
HED132-9747-GHA-11-01 (Flanigan)
USAID/HED 07/01/11-06/30/14
$550,000 .3 calendar months
University of Ghana – Brown University
Academic Partnership to Address HIV/AIDS in Ghana
The goal of this project is to strengthen the medical infrastructure in Ghana to better address HIV/AIDS and the specific issues associated with that disease in Ghana.
Role: Co-Investigator
****5R01AI079085 (Fichorova)
NIH/NIAID 07/01/09-06/30/14
$31,919 .90 calendar months
Molecular T. vaginalis host interactions in relevance to inflammatory sequelae
The specific aims are to: 1) define the roles of galectins as vaginal innate immunity modulators and host receptors for T. vaginalis LPG and identify related signaling pathways operating in the cervicovaginal epithelial cells in the context of normal and BV-associated microflora; 2) elucidate further the biochemical structure of LPG and the CPI-GC subdomains responsible for galectin binding and signaling; and 3) identify and validate molecular patterns of altered vaginal immunity in concurrent trichomoniasis and bacterial vaginosis that may enhance HIV infection risk.
Role: Co-Investigator
3P30AI042853-13S2 (Carpenter)
NIH/ CFAR Supplement 09/21/10-08/31/13
$395,683 1.8 calendar months
Cervical Cancer Screening See and Treat: How Best to Follow-up
The goal of this project id to compare the accuracy of VIA to conventional Pap smear or HPV typing as a follow-up tool to detect moderate to severe cervical neoplasia/cancer among HIV- positive women in Eldoret, Kenya who have undergone VIA and cryotherapy (> 6 months) with histology as a gold standard.
Role: Co-Investigator
UM1AI068618 (McElrath)
Fred Hutchinson Cancer Research Center 06/01/11-08/31/13
$79,264 1.2 calendar months
Development of a Systems Biology Platform for the Assessment of Mucosal Innate and Adaptive Immunity
Role: Co-Investigator
UM1AI068618 (McElrath)
Fred Hutchinson Cancer Research Center 06/01/11-08/31/13
$79,104 1.2 calendar months
Integrated Single Cell Assays for Multidimensional Analysis of HIV Mapping
Role: Co-Investigator
200-2010-37372 (Kojic)
CDC 09/28/10-09/27/12
$437,758 .3 calendar months
Study to Understand the Natural History of HIV & AIDS in the Era of Effective Therapy SUN)
The major goals of this project are to study the many manifestations, morbidities, and moralities of Human Immunodeficiency Virus (HIV) in women in the post Highly Active Antiretroviral Therapy (HAART) era (since 1996) and to incorporate HIV prevention activities into HIV medical care.
Role: Co-PI
5R25TW008102 (Cu-Uvin)
NIH/FIC 08/01/08-07/31/13
$350,000 .6 Calendar Months
Interdisciplinary Framework in Global health at Brown University
The goal of this project is to stimulate students and faculty to engage in multi-interdisciplinary global health activities.
Role: PI
5K24AI066884 (Cu-Uvin)
NIH/NIAID 08/15/05-6/30/11
$683,645 0.3 calendar months
Antiviral Therapy and HIV in the Genital Tract of Women
The goal of this project for a Mid-career Investigator Award in Patient-Oriented Research (K24) is to provide the framework within which I can mentor junior clinical investigators in patient-oriented research focused on critical issues related to HIV in women.
Role: PI
5U01AI066050 (Friedman)
NIH/NIAID 04/01/06-03/31/11
$18,870 .72 calendar months
S. Japonicum and Birth Outcomes: Randomized Controlled Trial
This grant explores the treatment of schistosomiasis among pregnant women and follows the outcomes of their babies.
Role: Co-Investigator
RO1AI 40350-07 (Cu-Uvin)
NIAID 04/15/97-04/30/10
$2,829,010
Antiviral Therapy and HIV in the Genital Tract of Women
This study will evaluate the relative dynamics of viral failure and viral replication in the female genital tract, assess drug exposure and patterns of drug resistance, and to evaluate cellular reservoirs in the female genital tract.
Role: PI
3D43TW000237 (Mayer)
NIH/FIC 01/01/08-12/31/09
$100,000
Fogarty/Moi Cancer Supplement
This training supplement will focus on the HIV/AIDS and cancer prevention strategies in the international setting.
Role: Co-Investigator
3D43TW000237 (Mayer) NIH/FIC 01/01/08-06/31/09
$100,000
Fogarty Indian Council on Medical Research Supplement
This training supplement will focus on the HIV/AIDS prevention strategies in the international setting.
Role: Co-investigator
Brown University/Women & Infants Hospital (Phipps)
Center of Excellence in Women's Health
Women and Infants Hospital/DHHS 10/01/04-09/30/07
The aim of this grant is to establish and center of excellence in women’s care and research at Brown University.
Role: Director, Research Component
R03 TW6981-01 (Cu-Uvin)
FIRCA/NIH 040/1/04-06/30/05
$121,382
Genital Tract HIV Shedding in Cambodian Women
The objectives are to determine the effect of generic antiretroviral medicines on genital tract HIV subtype E shedding and to determine factors associated with genital tract HIV-a shedding in Cambodian women.
Role: PI
World AIDS Foundation (Cu-Uvin)
$105,000 09/31/03-05/31/05
Establishing a Women’s Clinic in Cambodia
The aim of this grant is to establish a center for care for HIV-infected Cambodia women and to provide training to Cambodian health care professionals on the comprehensive care of HIV-infected women, to improve research readiness for future projects related to HIV in women.
Role: PI
Subcontract with Fenway (Mayer)
NIH
Prevention Trials Network (PTN) 7/1/2000-6/30/2005
$2,036,315
The PTN is established to evaluate HIV prevention interventions among different high risk populations. Studies include evaluation of microbicides to prevent sexual transmission of HIV.
Role: Co-investigator
5H4A-HA00013 (Mayer)
07/01/03-06/30/05
New England AIDS Education and Training Center
The objective of this program is to develop and coordinate education programs on HIV/AIDS infection for health care providers, residents, and students, in collaboration with the NEATC.
Role: Course Director
1 RO1 MH64455 (Morrow)
NIH 9/1/2001-8/31/2004
$1,125,000
A Contextual Model of Microbicide Acceptability
The goal of this project is to develop an instrument to be used for assessing the acceptability of microbicides.
Role: Co-investigator
1R21 AI48133-01 (Kozlowski)
NIH/NIAID 09/01/00 – 08/30/03
E. Coli LT as a Rectal and Vaginal Mucosal Adjuvant
The major goals of this project are 1) to evaluate the safety and establish doses of LT that can be administered in the rectum and vagina of women, and 2) to test the adjuvanticity of LT at these sites by evaluating immune responses induced in groups of women who receive rectal and vaginal immunizations with antigen or antigen plus LT.
Role: Co-investigator
RO1 AI40350 (Supplement) (Cu-Uvin)
NIDA 040/1/99-03/31/00
Effect of Directly Observed Antiretroviral Therapy on Plasma and Cervicovaginal HIV-1 RNA Levels among HIV-Infected Substance Abusing Women: Principal Investigator
The aim of the project was to determine the feasibility of using DOT among substance abusing women to decrease plasma and genital tract viral load.
Role: PI
U64/CCU106795 (Carpenter)
CDC 10/01/91 –09/29/00
HIV Epidemiology Research Study (HERS)
The HERS was a longitudinal study to determine the natural history of HIV infection among U.S. women.
Role: Co-investigator
HERS Substudy (Cu-Uvin)
CDC 040/1/98 – 12/31/00
Peripheral and Mucosal Immune Reconstitution after Highly Active Antiretroviral Therapy in HIV-Positive Women
The substudy was to assess mucosal immune reconstitution among women starting highly active antiretroviral therapy.
Role: Principal Investigator
RO1 HD33215 (Mayer)
NICHD 05/01/95- 04/30/98
Cervicovaginal Inflammation and Infection and HIV Load
The aim of the study was to assess the effect of cervicovaginal inflammation on HIV shedding in the female genital tract.
Role: Co-investigator
RO1 A135543 (Flanigan)
NIH-NIAID 11/01/93-10/31/97
Induction of Anti-HIV Ig A in Rectum and Cervix of Women
The study evaluated the induction of immune responses in the rectum and vagina using cholera toxin.
Role: Co-investigator
NO1-HD-3-3162 (Cu-Uvin)
NICHD 03/01/97- 02/28/98
The Influence of Ovulatory Phase on the Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions from HIV-Seropositive Women: Women’s Health Study (WHS) 001
The study evaluated the effect of the menstrual cycle on HIV shedding in the genital tract.
Role: PI
2. Cu-Uvin, Bardeguez A, Chibwesha A. Vertical Transmission of HIV and Therapeutic Interventions . NRTI and NNRTI in AIDS Therapy. Edited by Skowron G, 2006.
5. Cu-Uvin S, Bardeguez A, Chibwesha C. "Vertical Transmission of HIV and Therapeutic Interventions (NRTIs and NNRTIs). In Reverse Transcriptase Inhibitors in HIV/AIDS Therapy. Humana Press. Eds. Gail Skowron, M.D. and Richard Ogden, PhD, 2006, 425-470.
4. Powrie R, Cu-Uvin S. HIV Infection in Special Populations: HIV Infection in Women. HIV, American College of Physicians. Edited by Libman H. 3rd edition, 2006.
62. Cu-Uvin S. Effect of the menstrual cycle on virological parameters. J Acquir immune Def Syndr 38 : S33-34, March 2005.
57. Viscidi RP, Snyder B, Cu-Uvin S, Hogan J, Clayman B, Klein S, Sobel J, Shah KV. Human Papillomavirus (HPV) Capsid Antibody Response to Natural Infection and Risk of Subsequent HPV Infection in Human Immunodeficiency Virus-Positive and -Negative Women. Cancer Epid, Biomarkers, Prevention 14(1):283-8, Jan. 2005.
61. Newstein M. Losikoff P. Caliendo A. Ingersoll J. Kurpewski J. Hanley D. Cerezo J. Ramratnam B. Cu-Uvin S. Prevalence and persistence of nonnucleoside reverse transcriptase inhibitor mutations in the female genital tract. Journal of Acquir Immune Defic Syndr. 38(3):364-6, 2005 Mar 1.
63. Morris AB, Dobles AR, Cu-Uvin S, Zorilla C, Anderson J, Harwell J, Keller J, Garb J. Protease inhibitor use in 233 pregnancies. J Acquir Immune Defic Syndr 40(1) : 30-33, Sept. 2005.
11. Harwell J, Cu-Uvin S. Measuring HIV in the female genital tract and how this affects sexual and reproductive choices. Harvard Health Policy Review 6:57-66, Spring 2005.
60. Tohill B, Heilig C, Klein R, Rompalo A, Cu-Uvin S, Brown W, Duerr A. Vaginal flora morphotypic profiles and assessment of bacterial vaginosis in women at risk for HIV infection. Infect Dis Obstet Gynecol 12 :121-126, 2004.
58. Quayle AJ, Shah M, Cu-Uvin S, Politch JA, Chou C, Anderson DJ, Tuomala R, Crowley-Nowick PA, Duerr A. Implications of blood contamination for assessment of local cellular immunity in the endocervix. AIDS Res Hum Retroviruses 20(5):543-6, 2004.
56. Remollino C, Brown H, Adelson-Mitty J, Clarke J, Spaulding A, Boardman L, Flanigan TP, Cu-Uvin S. Lower genital tract infections among HIV-seropositive and HIV-seronegative incarcerated women: a mandate for screening and treatment in prisons. J Correctional Health Care 10:527-42, 2004.
55. Theng T, Phan S, Pugatch D, Harwell J, Rufner KM, Chhi Mean V, Mayer KH, Cu-Uvin S. HIV-1 cord-blood seroprevalence of parturient women in Sihanoukville, Cambodia. International J of STD & AIDS 15:419-421, 2004.
54. Paramsothy P, Duerr A, Heilig C, Cu-Uvin S, Anderson J, Schuman P, Klein R for the HER Study Group. Abnormal vaginal cytology in HIV-infected and at-risk women after hysterectomy. JAIDS 35:484-491, 2004.
59. Min SS, Corbett AH, Rezk N, Cu-Uvin S, Fiscus SA, Petch L, Cohen MS, Kashuba AD. Protease Inhibitor and Nonnucleoside Reverse Transcriptase Inhibitor Concentrations in the Genital Tract of HIV-1-Infected Women. J Acquir Immune Defic Syndr. 15;37(5):1577-1580, Dec. 2004.
53. Natividad-Villanueva G, Santiago E, Manalastas R, Brown HW, Ingersoll J, Caliendo AM, Mayer KH, Cu-uvin S. Human immunodeficiency virus in the plasma and cervicovaginal secretions in Filipino women. International J of STD & AIDS 14: 826-829, 2003.
49. Schuman P, Ohmit S, Klein R, Duerr, Cu-Uvin S, Jamieson D, Anderson J, Shah K for the HERS. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)- seropositive and at-risk HIV-seronegative women. J Infect Dis 188:128-136, 2003.
47. Harlow S, Cohen M, Ohmit S, Schuman P, Cu-Uvin S, Lin X, Greenblatt R, Gurtman A, Khalsa A, Minkoff H, Young M, Klein R. Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in HIV-seropositive women. Am J Obstet Gynecol 188:881-886, 2003.
45. Duerr A, Helig CM, Miekle SF, Cu-Uvin S, Klein RS, Rompalo A, Sobel JD. HER Study Group. Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women; risk factors and severity. Obstet Gynecol 101(3):548-56, 2003.
44. Viscidi R, Ahdieh-Grant L, Clayman B, Fox K, Massad L, Cu-Uvin S, Shah K, Anastos K, Squires K, Duerr A, Jamieson D, Burk R, Klein R, Minkoff H, Palefsky J, Strickler H, Schuman P, Piessens E, Miotti P. Serum immunoglobluin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. J Infect Dis 187: 194-205, 2003.
46. Harwell JI, Moench T, Mayer KH, Chapman S, Rodriguez I, Cu-Uvin S. A pilot study of treatment of bacterial vaginosis with a buffering vaginal microbicide. J Women's Health 12: 255-259, 2003.
48. Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, Duerr A, Massad LS, Celentano DD, Hall C, Fazzari M, Cu-Uvin S, Beacon M, Schuman P, Levine AM, Durante AJ, Gange S, Melnick S, Burk R. Human papillomavirus 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 95:1062-71, 2003.
50. DePasquale MP, Brown AJL, Cu-Uvin S, Ingersoll J, Caliendo A, Sutton L, Donahue S, D'Aquila R. Differences in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy. J Acquir Immune Defic Syndr 34:37-44,2003.
52. Madhivanan P, Cu-Uvin S, Govindaraian M, Mayer K, Wilson K, Hemalatha R, Solomon S. Prevalence of cervical dysplasia among women attending HIV care in Chennai, South India. J of Obstet Gynecol of India 53: 367-370, 2003.
43. Jamieson DJ, Duerr A, Burk R, Klein RS, Paramsothy P, Schuman P, Cu-Uvin S, Shah K for the HIV Epidemiology Research Study Group. Characterization of genital human papilloma virus infection in women with or at risk for HIV infection. Am J Obstet Gynecol 186:21-7, 2002.
42. Wiilliams S, Flanigan TP, Cu-Uvin S, Mayer K, Williams P, Ettore CA, Artenstein AW, Duerr A, Van Cott TC. Human Immunodeficiency Virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1. Clin Infect Dis ;35:611-617,2002.
39. Larsson M, Wilkens DT, Fonteneau JF, Beadle TJ, Merritt MJ, Kost R, Haslett PAJ, Cu-Uvin S, Bhardwaj N, Shacklett B. Amplification of low-frequency antiviral CD8+ T-cell responses using autologous dendritic cells. AIDS 16(2); 171-180, 2002 .
37. Silverberg MJ, Ahdieh L, Munoz A, Anastos K, Burk R, Cu-Uvin S, Duerr A, Greenblatt R, Klein RS, Massad S, Minkoff H, Muderspach L, Palefsky J, Piessens E, Schuman P, Watts H, Shah K. The impact of HIV infection and immunodeficiency on human papilloma virus type 6 or 11 infection and on genital warts. Sexually Trans Dis 29:427-435, 2002.
38. Kozlowski P, Williams SB, Lynch R, Flanigan TP, Patterson R, Cu-Uvin S, Neutra MR. Differential induction of mucosal and systemic antibody responses in women after nasal,rectal, or vaginal immunization:influence of the menstrual cycle. J of Immunol 169: 566-574, 2002.
40. Jamieson DJ, Duerr A, Burk R, Klein RS, Paramsothy P, Schuman P, Cu-Uvin S, Shah K for the HIV Epidemiology Research Study Group. Characterization of genital human papilloma virus infection in women with or at risk for HIV infection. Am J Obstet Gynecol ;186:21-7,2002.
Prevalence, Incidence, and Persistence or Recurrence of Trichomoniasis among Human Immunodeficiency Virus (HIV)-Positive Women and among HIV-Negative Women at High Risk for HIV Infection. Clin Infect Dis. 34(10):1406-11,2002.
9. Nahvi S, Flanigan TP, Cu-Uvin S. Processing of semen from human immunodeficiency virus-seropositive men for use in insemination of seronegative women. Am J Obstet Gynecol 184:1048-1049, 2001.
35. Al-Harthi L, Kovacs A, Coombs R, Reichelderfer P, Wright D, Cohen M, Cohn J, Cu-Uvin S, Watts H, Lewis S, Beckner S, Landay A. A menstrual cycle pattern for cytokine levels exist in HIV-positive women: implication for HIV vaginal and plasma shedding. AIDS 15:1535-1543, 2001.
34. Coombs R, Wright D, Reichelderfer P, Burns D, Cohn J, Cu-Uvin S, Baron P, Cohen M, Landay A, Lewis S. Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women. J Infect Dis 184:1187-91, 2001.
32. Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, Safaeian M, Astemborski J, Daniel R, Shah K. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus-positive and HIV-negative women. J Infect Dis 184:682-90, 2001.
30. Warren D, Klein RS, Sobel J, Kieke B, Brown W, Schuman P, Anderson J, Cu-Uvin S, Mayer K, Jamieson DJ, Holmberg S, Duerr A for the HIV Epidemiology Research Study Group. A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection. Infectious Diseases in Obstetrics and Gynecology 9:133-141, 2001.
28. Simbulan NP, Aguilar AS, Flanigan TP, Cu-Uvin S. High-risk behaviors and the prevalence of sexually transmitted diseases among women prisoners at the women state penitentiary in Metro Manila. Social Science and Medicine Journal 52: 599-608, 2001.
29. Mayer KH, Peipert J, Fleming T, Fullem A, Moench T, Cu-Uvin S, Bentley M, Chesney M, Rosenberg Z. The Safety and Tolerability of BufferGelTM , A Novel Vaginal Microbicide Studied in U. S. Women. Clin Infect Dis 32:476-482,2001.
31. Cu-Uvin S, Hogan JW, Caliendo AM, Harwell J, Mayer KH, Carpenter CCJ for the HIV Epidemiology Research Study Group. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis 33:894-896, 2001.
33. Jamieson DJ, Duerr A, Klein RS, Paramsothy P, Brown W, Cu-Uvin S, Rompalo A, Sobel J. Longitudinal analysis of bacterial vaginosis: findings from the HIV Epidemiology Research Study. Obstet Gynecol 98:656-63, 2001.
36. Brown H, Vallabhaneni S, Solomon S, Mothis S, McGarvey S, Jackson T, Putcha M, Brenner S, Mate K, Cu-Uvin S. Attitudes towards prenatal HIV testing and treatment among pregnant women in southern India. International J of STD & AIDS 12(6):390-4, 2001.
10. Nahvi, Shadi MD. Flanigan, Timothy P. MD. Cu-Uvin, Susan MD. Semen processing for HIV-discordant couples: Reply. Am J Obstet Gynecol 185(6):1433-4, 2001.
3. Mileno MD and Cu-Uvin S. HIV and other Infections in Pregnancy in the Tropics. In: Contemporary Obstetrics and Gynecology for Developing Countries. Okonofua, F; Odunsi, K; Briggs ND, Otubu, JA (Eds.). West African Publishers, Lagos, Nigeria, 2000.
19:187-193, 2000.
25. Reichelderfer P, Coombs R, Wright D, Cohn J, Burns D, Cu-Uvin S, Baron P, Cohen M, Landay A, Beckner S, Lewis L, Kovacs A. Effect of Menstrual Cycle on Human Immunodeficiency Virus Type 1 Levels in the Peripheral Blood and Genital Tract. AIDS 14:2101-2107, 2000.
24. Morris AB, Cu-Uvin S, Harwell JI, Garb J, Zorilla C, Vajaranant M, Dobles AR, Jones TB, Carlan S, Allen DY. Multicenter review of protease inhibitors in 89 pregnancies. J Acquir Immun Def Syndr 25:306-311, 2000.
22. Harlow S, Schuman P, Cohen M, Ohmit S, Cu-Uvin S, Lin X, et al. The Effect of Human Immunodeficiency Virus Infection on Menstrual Dysfunction. J Acquir Immun Def Syndr 24:68-75, 2000
20. Al-Harthi L, Wright D, Anderson A, Cohen M, Matiyahu D, Cohn J, Cu-Uvin S, Burns D, Reichelderfer P, Lewis S, Beckner S, Kovacs A, Landay A. The impact of ovulatory cycle on cytokine production: evaluation of systemic, cervicovaginal, and salivary compartments. J Interferon and Cytokine Res 20:719-24, 2000.
19. Newman S, Sarin P, Kumarasamy K, Amalraj K, Rogers M, Madhivanan P, Flanigan T, Cu-Uvin S, McGarvey S, Mayer K, Solomon S. Marriage, monogamy, and HIV: a profile of HIV-infected women in south India. International J of STD & AIDS. 11: 250-253, 2000.
17. Cu-Uvin S, Caliendo A, Reinert S, Chang A, Juliano-Remollino C, Flanigan TP, Mayer KH, Carpenter CCJ. Effect of Highly Active Antiretroviral Therapy on Cervicovaginal HIV-1 RNA. AIDS 14:415-421, 2000.
18. Farley JL, Mitty J, Lally M, Burzynski J, Tashima K, Rich J, Cu-Uvin S, Spaulding A, Normandie L. Snead M, Flanigan TP. Comprehensive Medical care Among HIV-Positive Incarcerated Women: The Rhode Island Experience. J Women's Health 9:51-56, 2000.
Flanigan TP, Carpenter CCJ, Nixon DF (2000), Quantification of HIV-1-specific
23. Cu-Uvin S, Wright DJ, Anderson D, Kovacs A, Watts H, Cohn J, Landay A, Reichelderfer P. Hormonal Levels Among HIV-1-Seropositive Women Compared to High-Risk HIV-Seronegative Women During the Menstrual Cycle. J Women's Health 9:857-863,2000.
26. Kozlowski PA, Lynch RM, Patterson RR, Cu-Uvin S, Flanigan TP, Neutra MR. Modified wick method using weck-cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody. JAIDS 24:297-309, 2000.
1. Committee on Perinatal Transmission of HIV, Institute of Medicine. Reducing the Odds: Preventing Perinatal Transmission of HIV in the United States. Edited by Stoto MA, Almario DA, McCormick MC. Washington, DC. National Academy Press; 1999.
7. Cu-Uvin S. Antiretroviral Treatment During Pregnancy. Improving the Management of HIV Disease (IAS-USA) 7:14-18, 1999.
16. McCormick Mc, Davidson EC, Stoto MA for the Committee on Perinatal Transmission of HIV. Preventing Perinatal Transmission of Human Immunodeficiency Virus in the United States. Obstet Gynecol 94:795-8,1999.
15. Cu Uvin S, Hogan J, Warren D, Klein RS, Peipert J, Schuman P, Holmberg S, Anderson J, Schoenbaum E, Vlahov D, Mayer KH. Prevalence of Lower Genital Tract Infections Among HIV-Seropositive and HIV-Seronegative Women. Clin Infect Dis 29:1145-50,1999.
14. Kozlowski PA, Cu-Uvin S, Neutra MR, Flanigan TP. Mucosal Vaccination Strategies for Women. J Infect Dis 179 (Suppl 3):S493-S498, 1999.
6. Star J, Powrie R, Cu-Uvin S, Carpenter CCJ. Should women with human immunodeficiency virus be delivered by cesarean? Obstet Gynecol 94:799-801, 1999.
8. IAS Position Paper on Prevention of HIV-1 Mother-to-Child Transmission. International AIDS Society, 1-7, July,1999.
13. Cu Uvin S, Caliendo AM, Reinert SE, Mayer KH, Flanigan TP, Carpenter CCJ. HIV-1 in the Female Genital Tract and the Effect of Antiretroviral Therapy. AIDS 12:826-7, 1998.
12. Farrar D, Aromin I, Cu Uvin S, Mileno M. Hypospadias Associated with the Use of High Dose Megestrol Acetate in an HIV Infected Woman. Genitourinary Med 73:226, 1997.
11. Ruiz R, Cu Uvin, S, Fiore T, Flanigan TP. Toxoplasmosis in HIV-positive Women: Seroprevalence and the Role of Prophylaxis in Preventing Disease. AIDS 11:119, 1997.
10. Cu Uvin S, Parekh B, Anderson D. Human Immunodeficiency Virus-1 Shedding in the Genital Tract of a Female Long-term Nonprogressor Without Detectable Plasma Human Immunodeficiency Virus Ribonucleic Acid. Am J Obstet Gynecol, 177:490-91, 1997.
9. Cu Uvin S, and Caliendo AM. Cervicovaginal Human Immunodeficiency Virus Secretion and Plasma Viral Load in Human Immunodeficiency Virus-Seropositive Women. Obstet & Gynecol 90:739-743, 1997.
7. Kozlowski PA, Cu Uvin S, Neutra MR, Flanigan TP. Comparison of the Oral, Rectal, and Vaginal Immunization Routes for Induction of Antibodies in Rectal and Genital Tract Secretions of Women. Infect & Immun 65:1387-94, 1997.
6. Farrar DJ, Cu Uvin S, Caliendo A, Costello S, Murphy DM, Flanigan TP, Mayer KH, Carpenter CCJ. Detection of HIV-1 RNA in Vaginal Secretions of HIV-Seropositive Women Who Have Undergone Hysterectomy. AIDS 11:1296-7, 1997.
8. Quesnel A, Cu Uvin S, Murphy D, Ashley RL, Flanigan T, Neutra MR. Comparative Analysis of Methods for Collection and Measurement of Immunoglobulins in Cervical and Vaginal Secretions of Women. J Immun Methods 202:153-161, 1997.
5. Cu Uvin S, Flanigan TP. Human Immunodeficiency Virus Infection and Sexually Transmitted Diseases. Medicine and Health Rhode Island 80:335-38, 1997.
4. Flanigan TP, Cu Uvin S, Rich JD, Mileno MD, Vigilante K, Tashima K. Update of HIV and AIDS in North America. Medicine and Health, Rhode Island 79:180-187, 1996.
5. Cu Uvin S, Flanagan K, Culff K, et al. Cervical Dysplasia and HIV in Women Inmates. J Women's Health 5:603-608, 1996.
4. Cu Uvin S, Flanigan TP, Rich JD, Mileno MD, Mayer KH, Carpenter CCJ. HIV and AIDS Among North American Women. Am J Med 101:316-322, 1996.
3. Boardman LA, Peipert, JF, Cooper A, Cu Uvin S, Flanigan TP, Raphael SI. Cytologic/Histologic Discrepancy in HIV-Positive Women Referred to a Colposcopy Clinic. Obstet & Gynecol 84:1016-20, 1994.
2. Cu Uvin S, McLean C, Flanigan TP, Fiore T, Jesdale B, Peipert J, Carpenter CCJ. Cervical Cytologic Abnormalities in HIV Seropositive Women: Cytologic and Histologic Correlation. J Womens Health 3:179-184, 1994.
2. Cu-Uvin, S, Flanigan TP, Carpenter CCJ. Routine Gynecologic Monitoring of HIV seropositive Women: Research and Recommendations. AIDS Reader 3:133-40, 1993.
1. Flanigan TP, Cu-Uvin, S, Fiore T, Vigilante K, Kizirian J, Carpenter CCJ. HIV Infection in Rhode Island Women. Rhode Island Medicine 76:463-466, 1993.
3. Flanigan TP, Cu-Uvin S, Carpenter CCJ, Vigilante K. Spectrum of Clinical Illness among Women Infected with the Human Immunodeficiency Virus. Opportunistic Complications of HIV 2:15-22, 1993.
51. Harwell J, Flanigan TP, Mitty J, Macalino G, Caliendo A, Ingersoll J, Stenzel M, Carpenter CCJ, Cu-Uvin S. Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence. AIDS 17:1990-1993, 2003.
1. Cu S., Abalos J, Puertollano, et al. Existence of Kidney Disease in Pregnant Hypertensives. Philippine Journal of Obstetrics and Gynecology April-June, 59-74, 1988.
T-cell responses at the mucosal cervicovaginal surface. AIDS 14:1911-1915, 2000.
64. Koshiol JE, Schneider JC, Jamieson D, Marshall S, Duerr A, Heilig C, Shah K, Klein R, Cu-Uvin S, Schuman P, Celentano D, Smith J. Time to clearance of Human Pappiloma Virus (HPV) by type and Human Immunodeficiency Virus (HIV) status. International J of Cancer ( in press).
41. Cu-Uvin S, Ko H; Jamieson D; Hogan J; Schuman P; Anderson J; Klein R
reproducibility of human papillomavirus identification in cervical specimens
27. Daniel R, Ahdieh L, Hayden D, Cu-Uvin S, Shah KV. Intra-laboratory
21. Shacklett BL, Cu-Uvin S, Beadle TJ, Pace CA, Fast NM, Donahue SM, Caliendo AM,
ORIGINAL SCIENTIFIC PUBLICATIONS:
by a polymerase chain reaction-based assay, J of Clin Virol
OTHER PUBLICATIONS :
| Year | Degree | Institution |
|---|---|---|
| 1982 | MD | University of Phiippines Diliman |
| 1978 | BS | University of Phiippines Diliman |
| Clinical Fellow | Brown University, The Miriam Hospital, hiv/aids related diseases | 1992-1995 | Providence, RI |
| Postdoctoral Training | Kobe University, fetal therapy | 1991-1991 | Japan |
| Postdoctoral Training | National University of Singapore, antenatal diagnosis and obstetric- gynecologic ultrasonography | 1989-1989 | Singapore, Singapore |
| Postdoctoral Training | Tottori University, hiv/aids virology | 1988-1988 | Japan |
| Resident | University of the Philippines, Philippine General Hospital, obstetrics and gynecology | 1984-1987 | Philippines |
| Intern | University of the Philippines, Philippine General Hospital, medicine | 1982-1983 | Philippines |
2003 Bruce M. Selya Annual Award for Research Excellence, Lifespan, Brown University
2004 Global Alliance for the Immunization Against AIDS (GAIA) Foundation and City of Providence, Hope is a Vaccine Award
2005 The Rhode Island Community Planning Group for HIV Prevention, The HIV Prevention Unsung Hero Award
2005 Constance B. Wofsy Women's Health Investigator Award, The AIDS Clinical Trials Group
2006 The First Annual Health Breakthrough Awards, Ladies Home Journal
2007 Community Partnership Award, Sojourner House
2007 Betty Marcus Women's Health Award, Betty Marcus Foundation
2007 Woman Physician of the Year, Rhode Island Medical Women's Association
2007 The Rhode Island 85, awarded by the Junior League of Rhode Island for Commitment to the Community, 85th Anniversary
2007 40 Women We Admire, Big Sisters of Rhode Island, 40th Anniversary
2008 Rhode Island Woman of the Year, Rhode Island Commission on Women
2010 - 2019 Certificate of Appreciation for Services on the Medical Admissions Committee from Alpert Medical School of Brown University
2019 - MPH Thesis Mentor Award in Recognition of Mentoring 5 MPH Theses since 2000 from Alpert Medical School of Brown University
| Name | Title |
|---|---|
| Harwell, Joseph | Clinical Associate Professor of Pediatrics, Clinical Associate Professor of Medicine |
| Kurtis, Jonathan | Stanley M. Aronson Professor of Pathology and Laboratory Medicine, Chair of Pathology and Laboratory Medicine, Executive Director of the MD-PhD Program |
| Kwara, Awewura | Associate Professor of Medicine |
| Tashima, Karen | Professor of Medicine |
Infectious Disease Society of America, Fellow
Infectious Disease Society of Obstetrics and Gynecology
International AIDS Society-USA
American Society for Colposcopy and Cervical Pathology
Rhode Island Medical Society
Philippine Obstetrics and Gynecology Society, Fellow
| Fellow, Infectious Disease Society of America | 2001- | ||
| Medical License | Massachusetts | 1998- | |
| Medical License | Rhode Island | 1994- | |
| Federal Licensure Examination | 1993- | ||
| ECFMG | 1983- | ||
| Visa Qualifying Examination | 1983- |
| Director. The Miriam Hospital & Brown University, 1999-2009 |
| Attending Physician. The Miriam Hospital, 1996-Present |
| Attending Physician. Philippine General Hospital, 1988-1992 |
| Resident. Philippine General Hospital, 1984-1987 |
UNIVERSITY TEACHING ROLES
1996-present - Fogarty HIV/AIDS Fellowship Faculty Mentor
1996-present - Speaker, Annual Brown University AIDS Program Forum
2000-present - Lecturer, BC 107, Burden of Disease in the Developing World
2002-2011 - Lecturer, Biomed 282, Pathophysiology, Infectious Diseases
2002-present - Preceptor, Brown Medical School and Lifespan Academic Medical Center, Internal Medicine Community Based Teaching Program
2003-present - Course Director, Brown University AIDS Program and New England AIDS Training Center,
Annual HIV in Women Symposium
2006-present - Brown Doctoring Course, Mentor
HOSPITAL TEACHING ROLES
1996-present - Immunology Center Attending, The Miriam Hospital, Providence, RI, 3 clinic sessions per week
1996-present - Inpatient and On-call Rounding, The Miriam Hospital, Providence, RI, one week per month
1996-present - Preceptor, Brown Medical School students, The Immunology Center, The Miriam Hospital, Providence, RI
2000-present - Lecturer, Brown University Infectious Disease Fellowship
2004-present - Lecturer, Core Curriculum, Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, RI
OTHER TEACHING ROLES
1996- Preceptor, Brown University Undergraduate Independent Study Projects
1997- Mentor, Summer Research Asssistantships, Undergraduate and Medical Students
2000- Mentor, Summer Undergraduate Teaching and Research Assistantship (UTRA)
2000- Thesis Adviser, Undergraduate students, Brown University
2005- Mentor, Research Supplement for Underrepresented Minorities
2005- Thesis Adviser, MPH candidate, Brown University
2005- Mentor, The Women and Infants /Brown National Center of Excellence in Women's Health
2005- Mentor, T32 training grant on Blood Borne Infections
2005- Mentor, BIRCH Program, Women and Infants Hospital
2008- Mentor, WHRH Program, Women and Infants Hospital
FOGARTY INTERNATIONAL TRAINEES
1996- present
Philippines:
Dr. Nymia Simbulan, Professor of Sociology, University of the Philippines
Dr. Guadalupe Natividad-Villanueva, Asst. Professor, Dept. of OB-GYN, University of the Philppines
Dr. Katherine Juliano Remollino, Asst. Professor, Dept. of OB-GYN, University of the Philippines
Dr. Maria Conception Manalo, Asst. Professor, Dept. Of Pediatrics, University of the Philippines
Dr. Dorothy Agdamag, Director, Microbiology and STD Research Laboratory, San Lazaro Hospital, Manila, Philippines
Dr. Josefina Tayag, Professor of Sociology, University of the Philippines
Dr. Reynaldo Imperial, Professor of Sociology, University of the Philippines
India:
Dr. Purnima Madhivanan, YRG Care, Chennai, India, PhD student, Univ. of California, Berkely
Dr. Sheila Shyramprasad, Director, Dept. of OB-GYN, C.S.Rainy Hospital, Chennai, India
Dr. Jessie Lionel, Associate Professor, OB-GYN, Christian Medical College, Vellore, India
Dr. Nomita Chandiok, OB-GYN, Microbicide Project, Indian Council of Medical Research
Cambodia:
Dr. Sok Pheng, Director, Sihanoukville Hospital, Cambodia
Dr. Theng Theany, Chief of OB-GYN, Sihanoukville Hospital, Cambodia
Dr. Lim Kruy, Director, Women's HIV Clinic, Center of Hope, Phnom Penh, Cambodia
Brazil:
Dr. Ana Lucia Ribeiro de Vasconcelos, Ministry of Health, National Program for HIV/AIDS
Dr. Angela Andrade, Dept. Of OB-GYN, Fio Cruz Hospital, Rio de Janeiro, Brazil
Kenya:
Dr. Hilary Mabeya, Chair, Department of Ob-Gyn, Moi University, Eldoret, Kenya
Dr. Rose Kosgei, Department of Ob-Gyn, Moi University, Eldoret, Kenya
Dr. Omenge Orango, Department of Ob-Gyn, Moi University, Eldoret, Kenya
.
